A Survey of the Quality of Web Based Information on the Treatment of Schizophrenia and Attention Deficit Hyperactivity Disorder

2003 ◽  
Vol 37 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Stephen Kisely ◽  
Greg Ong ◽  
Ashish Takyar

Objective: To systematically assess the quality, accountability and readability of Internet information on the treatment of schizophrenia and Attention Deficit Hyperactivity Disorder (ADHD), using a standardized pro forma. Method: We analysed the 20 most highly ranked pages on the treatment of ADHD and schizophrenia, identified by five common Internet search engines. Results: There was little overlap in the sites identified by different search engines. In the case of schizophrenia, one site was identified three times and another eight sites twice; while for ADHD four sites were identified twice. Accountability (Silberg score), presentation and readability, as assessed by the Flesch-Kincaid Grade Level score, were poor. Mean Silberg, presentation and Flesch-Kincaid Grade Level scores were 3.2 (range 0–9) out of 9, 1.9 (range 0–4) out of 4, and 11.5 (range 6.5–12.25), respectively. There was no statistical difference in scores between the two diagnoses. Depending on the recommendation, agreement with evidence-based practice for schizophrenia ranged from only 2 to 55% (mean = 2.8 (range 0–9) out of 12), while that for ADHD was from 14 to 54% (mean = 1.6 (range 0–6) out of 6). Only 50% of the sites advised readers to clarify information with an appropriate health professional. Interrater reliability in pro forma scores for schizophrenia and ADHD was high (r = 0.96 and 0.95, respectively, p < 0.0001). Sites in the top 10% of scores were significantly more likely to be owned by an organization or have an editorial board than those in the bottom 10%. Conclusions: The Internet contains misleading information on both schizophrenia and ADHD. The methodology used in this paper could be adapted for other psychiatric conditions.

2020 ◽  
Vol 26 (Suppl. 4-5) ◽  
pp. 274-282 ◽  
Author(s):  
Fabio Lugoboni ◽  
Anna Bertoldi ◽  
Rebecca Casari ◽  
Elisa Mantovani ◽  
Laura Morbioli ◽  
...  

2009 ◽  
Vol 19 (2) ◽  
pp. 83-105 ◽  
Author(s):  
Marina Danckaerts ◽  
Edmund J. S. Sonuga-Barke ◽  
Tobias Banaschewski ◽  
Jan Buitelaar ◽  
Manfred Döpfner ◽  
...  

2012 ◽  
Vol 5 ◽  
pp. JCNSD.S6691 ◽  
Author(s):  
Anna C. Shier ◽  
Thomas Reichenbacher ◽  
Harinder S. Ghuman ◽  
Jaswinder K. Ghuman

Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of childhood that can result in significant functional impairment, and if not adequately treated can lead to impaired quality of life. Pharmacotherapy is considered the first-line treatment for ADHD in children and adolescents. We review both recent literature and seminal studies regarding the pharmacological treatment of ADHD in children and adolescents. There is ample evidence for the efficacy and safety of both stimulants and non-stimulants in the treatment of ADHD. We review important aspects of evaluation and assessment and discuss first-line pharmacological treatments and as well as when to consider using alternative pharmacological agents. Treatment approaches to manage frequently seen comorbid disorders with ADHD are also covered.


Sign in / Sign up

Export Citation Format

Share Document